Quinolone Resistance Profiles and Mechanisms of Staphylococcus Aureus and Escherichia Coli From Humans, Chicken and Catfish Farms in Indonesia
QUINDO
1 other identifier
observational
480
0 countries
N/A
Brief Summary
The goal of this observational study is to reveal quinolone resistance profiles and mechanisms in S. aureus and E. coli in the human, animal and aquaculture sector in Blitar, Indonesia. The main questions it aims to answer are:
- Obtain the quinolone resistance profiles and mechanisms of S. aureus and E. coli in human health, animal health and aquaculture health sector in Blitar, Indonesia.
- Obtain the association of AMR and AMU data within and between the human health, animal health and aquaculture health sector in Blitar, for quinolones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2022
CompletedStudy Start
First participant enrolled
December 9, 2022
CompletedFirst Posted
Study publicly available on registry
December 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedDecember 15, 2022
December 1, 2022
23 days
December 7, 2022
December 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quinolone resistance profiles and mechanisms of S. aureus and E. coli in human health, animal health and aquaculture health sector in Blitar
As determined by Vitek, microdilution, and whole genome sequencing.
2023
Secondary Outcomes (1)
Association of AMR and AMU data within and between the human health, animal health and aquaculture health sector in Blitar, for quinolones
2023
Eligibility Criteria
Farmers of included farms and non-farmers. Non-farmers will be approached via public health center (puskesmas).
You may qualify if:
- Informed consent
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Dr. Soetomo General Hospitalcollaborator
- Balai Besar Laboratorium Kesehatan (BBLK) Surabayacollaborator
- National Institute of Health Research and Development, Ministry of Health Republic of Indonesiacollaborator
- Directorate of Veterinary Public Health, Ministry of Agriculture, Indonesiacollaborator
- Directorate of Animal Health, Ministry of Agriculture, Indonesiacollaborator
- Ministry of Marine and Fisheries, Indonesiacollaborator
- Utrecht Universitycollaborator
- Radboud University Medical Centercollaborator
- National Institute for Public Health and the Environment (RIVM)collaborator
Biospecimen
Culture of nasal and rectal swabs.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juliëtte A. Severin, MD PhD
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, Medical coordinator Unit infection prevention
Study Record Dates
First Submitted
December 7, 2022
First Posted
December 15, 2022
Study Start
December 9, 2022
Primary Completion
January 1, 2023
Study Completion
March 31, 2023
Last Updated
December 15, 2022
Record last verified: 2022-12